Vista Partners Publishes March 2013 Macroeconomic & Investment Newsletter

Topics Include: Market Forecast, The Three Trillion Dollar Gamble, Chicago Blackhawks, NBA Finals, Federal Stimulus Measures, Monthly Macroeconomic Commentary, Investment Ideas & More


SAN FRANCISCO, CA--(Marketwire - Mar 4, 2013) - Vista Partners ("Vista") announced today that it published its FREE macroeconomic/small cap oriented monthly newsletter for the month of March. Each monthly newsletter from Vista contains macroeconomic thoughts from Principal Analyst, Ross Silver, and monthly highlights of each covered small cap company. 

Ross Silver, Principal Analyst at Vista Partners, states in the newsletter, "ADVENTRX Pharmaceuticals (NYSE MKT: ANX) announced on Friday its plans to develop ANX-188 in complications of arterial disease, initially as an adjunct to thrombolytics in acute limb ischemia (ALI), a complication of peripheral arterial disease. Peripheral arterial disease affects an estimated 8 to 12 million people in the United States. ADVENTRX's stock price has risen nearly 39% in 2013." Mr. Silver also states, "Power Solutions International (OTCQB: PSIX) closed at a new 52-Week high of $22 last week and their stock price has risen approximately 30% in 2013. PSIX reported strong 4th quarter and year-end earnings results on Thursday and gave revenue guidance for 2013 & 2014. PSIX's revenue guidance for 2014 is targeted to be in a range of $310 to $330 million, a near 60% increase versus 2012 revenues taking the midpoint of sales guidance." 

To read more, please download the FREE March 2013 Macroeconomic & Investment Newsletter available at and click "Download Research & Newsletter" or CLICK HERE to gain access. 

The Companies featured in the FREE February Newsletter are: Acorn Energy, Inc., ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX), Algae.Tec Limited, Auxilio Inc. (OTCQB: AUXO), Ohr Pharmaceutical, Inc. (OTCQB: OHRP), PositiveID Corporation, ECOtality, Inc and Power Solutions International Inc. (OTCQB: PSIX). Other companies mentioned are Roche, Novartis, Selexys, Regeneron, Pfizer, Aramark, Lufthansa and others.

About Vista Partners:
Vista Partners LLC, founded in 2005, is a Registered Investment Advisor in the States of California and Oregon. The firm's professional staff has backgrounds in finance, corporate communications and investment banking.

Please follow us on Twitter @VistaPResearch & Facebook at Vista-Partners to receive updates, thoughts and ideas about and our coverage universe of companies and more.

Disclaimer & Disclosure:
We encourage readers to view a complete list of disclaimers and disclosures on our website:


Vista Partners LLC
Email Contact
View Comments (1)